LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | - | - | 200.0 | 403.0 | - | - | - | 603 |
1 | - | - | - | - | - | 6.0 | 22.0 | - | - | - | 28 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 31.0 |
1 | - |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 63 |
1 | 155 |
Number of post synapses: 603
Number of pre synapses: 28
Number of output connections: 52
Coverage factor: 1.0
Columnar completeness: 0.18
Area completeness: 0.36
Cell size (columns): 160
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#MeVP39 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | MeTu2a (R) | ACh | 232 | 232.0 | 35.5% | 35.5% |
1 | MeTu3a (R) | ACh | 107 | 107.0 | 16.4% | 51.9% |
2 | MeVPMe10 (L) | Glu | 84 | 84.0 | 12.9% | 64.8% |
3 | Cm4 (R) | Glu | 64 | 64.0 | 9.8% | 74.6% |
4 | MeTu3b (R) | ACh | 30 | 30.0 | 4.6% | 79.2% |
5 | MeVPaMe2 (L) | Glu | 25 | 25.0 | 3.8% | 83.0% |
6 | Dm-DRA1 (R) | Glu | 16 | 16.0 | 2.5% | 85.5% |
7 | Cm14 (R) | GABA | 14 | 14.0 | 2.1% | 87.6% |
8 | MeVPLo2 (L) | ACh | 11 | 11.0 | 1.7% | 89.3% |
9 | MeTu2b (R) | unclear | 8 | 8.0 | 1.2% | 90.5% |
10 | MeVPLo2 (R) | ACh | 6 | 6.0 | 0.9% | 91.4% |
11 | aMe4 (R) | ACh | 4 | 4.0 | 0.6% | 92.0% |
12 | Cm21 (R) | GABA | 4 | 4.0 | 0.6% | 92.6% |
13 | CT1 (L) | GABA | 4 | 4.0 | 0.6% | 93.3% |
14 | Cm-DRA (R) | ACh | 3 | 3.0 | 0.5% | 93.7% |
15 | Cm18 (R) | Glu | 3 | 3.0 | 0.5% | 94.2% |
16 | Cm28 (R) | unclear | 3 | 3.0 | 0.5% | 94.6% |
17 | MeTu3c (R) | ACh | 3 | 3.0 | 0.5% | 95.1% |
18 | MeVP14 (R) | ACh | 3 | 3.0 | 0.5% | 95.6% |
19 | Mi15 (R) | ACh | 3 | 3.0 | 0.5% | 96.0% |
20 | OA-AL2i4 (R) | OA | 3 | 3.0 | 0.5% | 96.5% |
21 | Cm34 (R) | Glu | 2 | 2.0 | 0.3% | 96.8% |
22 | Cm8 (R) | GABA | 2 | 2.0 | 0.3% | 97.1% |
23 | aMe17e (R) | Glu | 1 | 1.0 | 0.2% | 97.2% |
24 | aMe3 (R) | Glu | 1 | 1.0 | 0.2% | 97.4% |
25 | aMe6a (R) | ACh | 1 | 1.0 | 0.2% | 97.5% |
26 | Cm20 (R) | GABA | 1 | 1.0 | 0.2% | 97.7% |
27 | Cm22 (R) | GABA | 1 | 1.0 | 0.2% | 97.9% |
28 | Cm24 (R) | Glu | 1 | 1.0 | 0.2% | 98.0% |
29 | Dm8b (R) | Glu | 1 | 1.0 | 0.2% | 98.2% |
30 | HBeyelet (R) | His | 1 | 1.0 | 0.2% | 98.3% |
31 | MeVC21 (R) | Glu | 1 | 1.0 | 0.2% | 98.5% |
32 | MeVC27 (L) | unclear | 1 | 1.0 | 0.2% | 98.6% |
33 | MeVCMe1 (R) | ACh | 1 | 1.0 | 0.2% | 98.8% |
34 | MeVP15 (R) | ACh | 1 | 1.0 | 0.2% | 98.9% |
35 | MeVP29 (R) | ACh | 1 | 1.0 | 0.2% | 99.1% |
36 | MeVP46 (R) | Glu | 1 | 1.0 | 0.2% | 99.2% |
37 | MeVPaMe1 (R) | ACh | 1 | 1.0 | 0.2% | 99.4% |
38 | MeVPMe11 (L) | Glu | 1 | 1.0 | 0.2% | 99.5% |
39 | MeVPMe4 (L) | Glu | 1 | 1.0 | 0.2% | 99.7% |
40 | SLP249 (R) | unclear | 1 | 1.0 | 0.2% | 99.8% |
41 | Tm39 (R) | ACh | 1 | 1.0 | 0.2% | 100.0% |
instance | NT | total connections | connections /#MeVP39 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Cm14 (R) | GABA | 22 | 22.0 | 37.3% | 37.3% |
1 | MeTu2b (R) | unclear | 5 | 5.0 | 8.5% | 45.8% |
2 | MeTu3a (R) | ACh | 4 | 4.0 | 6.8% | 52.5% |
3 | MeTu3c (R) | ACh | 4 | 4.0 | 6.8% | 59.3% |
4 | FB8B (R) | unclear | 3 | 3.0 | 5.1% | 64.4% |
5 | MeVP14 (R) | ACh | 3 | 3.0 | 5.1% | 69.5% |
6 | MeVP15 (R) | ACh | 3 | 3.0 | 5.1% | 74.6% |
7 | aMe22 (R) | Glu | 2 | 2.0 | 3.4% | 78.0% |
8 | aMe4 (R) | ACh | 2 | 2.0 | 3.4% | 81.4% |
9 | MeTu3b (R) | ACh | 2 | 2.0 | 3.4% | 84.7% |
10 | Cm-DRA (R) | ACh | 1 | 1.0 | 1.7% | 86.4% |
11 | Cm18 (R) | Glu | 1 | 1.0 | 1.7% | 88.1% |
12 | Cm20 (R) | GABA | 1 | 1.0 | 1.7% | 89.8% |
13 | Cm21 (R) | GABA | 1 | 1.0 | 1.7% | 91.5% |
14 | Cm24 (R) | Glu | 1 | 1.0 | 1.7% | 93.2% |
15 | Cm27 (R) | Glu | 1 | 1.0 | 1.7% | 94.9% |
16 | MeTu2a (R) | ACh | 1 | 1.0 | 1.7% | 96.6% |
17 | MeVC20 (R) | Glu | 1 | 1.0 | 1.7% | 98.3% |
18 | MeVPaMe2 (R) | Glu | 1 | 1.0 | 1.7% | 100.0% |